MENU
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2026 All rights reserved. Tickeron Inc.
APVO
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Aptevo Therapeutics (APVO) Ownership - Who owns Aptevo Therapeutics?

Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
36
Web
https://www.aptevotherapeutics.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.97M
P/E Ratio
0.00
Total Cash
14.52M
Projected Growth
N/A
Total Debt
4.42M
Revenue
N/A
Risk (Beta)
2.79
Dividend Yield
N/A
Total Cash/Share
11.66
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
APVO
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
View AI-Driven Trading for APVO
A.I. Advisor
published General Information

General Information

a provider of immunology and cancer research services

Industry Biotechnology

Profile
Details
Industry
Biotechnology
Address
2401 4th Avenue
Phone
+1 206 838-0500
Employees
36
Web
https://www.aptevotherapeutics.com